🇺🇸 Pentosan Polysulphate Sodium in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 28 March 2025 – 28 March 2026
- Total reports: 1
Most-reported reactions
- Hepatic Pain — 1 report (100%)
Frequently asked questions
Is Pentosan Polysulphate Sodium approved in United States?
Pentosan Polysulphate Sodium does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Pentosan Polysulphate Sodium in United States?
Paradigm Biopharmaceuticals Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.